from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2402/-

LFCtreatmentdescriptionclass of inhibitor

-0.670

Amikacinug/mL Amikacintranslation

-1.286

Cap5-10ug/mL Capreomycintranslation

-2.432

Rox10-50 ug/mL Roxithromycintranslation

0.587

SM2-5 ug/mL Streptomycintranslation

-2.808

Tet5-10 ug/mL Tetracyclinetranslation

0.605

Rif0.2-5ug/mL Rifampicintranscription

0.065

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.790

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.525

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.384

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.286

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.394

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.643

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.102

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.194

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.541

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.111

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.216

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.378

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.080

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.480

KCN5-20 ug/mL Potassium cyaniderespiration

-0.300

NaN30.2-2 mM Sodium aziderespiration

0.456

Nigericin50 uM Nigericinrespiration

0.001

TRC10-150 ug/mL Triclosanrespiration

-0.427

TRZ10-25 ug/mL Thioridazinerespiration

-0.620

Valinomycin0.5-10 uM Valinomycinrespiration

-0.173

ZnSO42 mM ZnSO4respiration

1.057

menadione6-10 ug/mL Menadionerespiration

0.011

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.073

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.299

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.279

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.180

NRP_1Non-replicating persistence stage 1dosRassociated

0.524

Amp0.2mg/mL AmpicillincellWall

-0.420

Cephalexin20-100 ug/mL CephalexincellWall

-0.167

Cerulenin0.32-5 ug/mL CerulenincellWall

0.535

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.054

EMB10-20 ug/mL EthambutolcellWall

-0.202

Eta12-40 ug/mL EthionamidecellWall

0.035

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.083

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.981

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.902

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.113

BZA0.12 mg/mL BenzamidearomaticAmides

0.524

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.212

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.873

H2O24 mM hydrogen peroxideDNAdamaging

-0.396

Levo10 ug/mL LevofloxacinDNAdamaging

0.767

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-2.690

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.463

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.753

UVUV-irradiationDNAdamaging

0.161

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.082

Antimycin12.5-50 ug/mL Antimycin A?

-0.573

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.455

PA_110-50 ug/mL Antitubercular compound PA-1?

0.104

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.113

PA8240.2-2 ug/mL PA-824?

-0.268

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.150

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.839

Verapamil50 uM Verapamil?

-0.488

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.721

methoxatin10-20 ug/mL Methoxatin?